companies with glp 1 drugs GLP-1 Costs Explained: Managing Coverage Challenges The U.S. Food and Drug
Description
Renal effects of glucagon-like peptide in rats
Rena, G., Hardie, D
However, some patients report cramping, likely due to indirect factors such as electrolyte disturbances or rapid weight loss rather than direct drug effects

10.1016/j.cell.2007.05.047 38 LiangW.KhatriI.SchellekensH.GarssenJ.WesterhoutJ

The review evaluated whether a specific time to pause the use of a GLP-1 or dual GIP/GLP-1 RAs prior to anaesthesia could be recommended
adjusted HR, 1.79
